ProBioGen and Life Technologies Present Freedom (TM) CHO-S (TM) Platform, a Royalty-Free New cGMP Cell Line Development Kit
|| Print ||
|Tuesday, 17 May 2011 11:00 (UTC + 2)|
Berlin, Germany, May 17, 2011 / B3C newswire / - ProBioGen AG and Life Technologies Corporation announce the launch of the new Freedom™ CHO-S™ Kit as the result of a successful co-development. The kit was built for developing stable high yield production cell lines in less than 4 months, and is based on Life Technologies’ CHO-S™ Cells. The Freedom™ CHO-S™ Kit platform enables end-users the cost- and time-efficient creation of stable cell lines for research and commercial purposes. The kit’s applicability and efficiency was confirmed in several studies, in which antibody titers of 1 to 3 g/L have been obtained.
The kit is sold by Life Technologies.
A full documentation package is provided as part of a commercial use license. The package includes the cell line’s lineage as well as the history and the parental cGMP testing results.
About ProBioGen AG
Combined with its innovative scientific excellence and strong intellectual property base, ProBioGen covers the entire drug development value chain, including regulatory support for IND-filing. All of ProBioGen’s services and technologies are embedded in a total quality management system to assure compliance with international ISO and GMP standards (EMA/FDA). ProBioGen was founded in 1994 and is located in Berlin, Germany.